Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp, Lene Dreyer, Annette Hansen, Ib Tønder Hansen, Gina Kollerup, Louise Linde, Hanne M Lindegaard, Uta Engling Poulsen, Annette Schlemmer, Dorte Vendelbo Jensen, Signe Jensen, Gisela Hostenkamp, Mikkel Ostergaard

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

482 Citationer (Scopus)

Abstract

Udgivelsesdato: 2010-Jan
OriginalsprogEngelsk
TidsskriftArthritis & Rheumatism
Vol/bind62
Udgave nummer1
Sider (fra-til)22-32
Antal sider11
ISSN0004-3591
DOI
StatusUdgivet - 2010
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry'. Sammen danner de et unikt fingeraftryk.

Citationsformater